Akademisyen
MERAL TUNÇBİLEK
PROFESÖR
ANKARA ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 50
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
17
Q2
8
Q3
12
Q4
1
WoS (JCR)
Q1
4
Q2
10
Q3
12
Q4
18
TR Index
3
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
59.0%
Üst %1 payı
0.0%
Üst %10 payı
2.6%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Targeting Ovarian Cancer With Pyrimidine Nucleobase and Nucleoside Analogs: Synthesis, In Vitro Cytotoxic Activity, and Molecular Docking YÖKSİS SJR Q2 JCR Q2 OpenAlex 28.0%
- 2024 Exploration of novel 6,8,9-trisubstituted purine analogues: synthesis, in vitro biological evaluation, and their effect on human cancer cells YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 69.8%
- 2024 Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.9%
- 2023 A Novel 6,8,9-Trisubstituted Purine Analogue Drives Breast Cancer Luminal A Subtype MCF-7 to Apoptosis and Senescence through Hsp70 Inhibition YÖKSİS SJR Q3 JCR Q3 OpenAlex 54.7%
- 2023 Newly synthesized 6-substituted piperazine/phenyl-9-cyclopentyl containing purine nucleobase analogs act as potent anticancer agents and induce apoptosis via inhibiting Src in hepatocellular carcinoma cells YÖKSİS SJR Q1 JCR Q2 OpenAlex 51.5%
- 2021 Highly efficient chemical phosphorylation of 6-(4-phenylpiperazine-1-yl)-9-(β-D-ribofuranosyl)-9H-purine YÖKSİS SJR Q3 JCR Q4 OpenAlex 37.5%
- 2018 Synthesis of novel 6-substituted amino-9-( β - d -ribofuranosyl)purine analogs and their bioactivities on human epithelial cancer cells YÖKSİS SJR Q1 JCR Q2 OpenAlex 77.0%
- 2017 Synthesis of Some Substituted 6-Phenyl Purine Analogues and Their Biological Evaluation as Cytotoxic Agents YÖKSİS SJR Q3 JCR Q3 OpenAlex 62.1%
- 2017 New Drug Combination in Colorectal Cancer Treatment: Trifluridine and Tipiracil YÖKSİS SJR Q4 JCR Q4 OpenAlex 21.5%
- 2012 Synthesis of Novel 6 4 Substituted piperazine 1 yl 9 ribofuranosyl purine Derivatives Which Lead to Senescence Induced Cell Death in Liver Cancer Cells YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.0%
- 2009 Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.0%
- 2009 Synthesis and antimicrobial evaluation of some new substituted purine derivatives YÖKSİS SJR Q1 JCR Q2 OpenAlex 69.0%
- 2008 Synthesis and crystal structure of 1 benzyl 2 4 benzyloxyphenyl 5 6 dichloro 1H benzimidazole YÖKSİS SJR Q3 JCR Q2 OpenAlex 60.3%
- 2006 Synthesis of New 3 Substituted Phenacyl 5 3 4H 4 oxo 1 benzopyran 2 yl benzylidene 2 4 thiazolidinediones and their Antimicrobial Activity YÖKSİS SJR Q1 JCR Q2 OpenAlex 64.4%
- 2004 Antioxidant properties of flavone 6 4 carboxaldehyde oxime ether derivatives YÖKSİS SJR Q2 JCR Q4 OpenAlex 53.2%
- 2004 Evaluation of the Antioxidant Effects of Some Flavonylthiazolidinediones by Determining Their Effects on Lipid Peroxidation Superoxide Anion Formation and 2 2 Diphenyl 1 picrylhydrazyl Stable Free Radical YÖKSİS SJR Q1 JCR Q3 OpenAlex 61.4%
- 2003 Synthesis and hypoglycemic activity of some substituted flavonyl thiazolidinedione derivatives fifth communication flavonyl benzyl substituted 2 4 thiazolidinediones YÖKSİS JCR Q4 OpenAlex 60.6%
- 2003 5 Nor Carbocyclic Ribavirin YÖKSİS SJR Q2 JCR Q4 OpenAlex 60.2%
- 2003 9 Deaza 5 noraristeromycin YÖKSİS SJR Q1 JCR Q1 OpenAlex 49.9%
- 2001 Antioxidant activity of 4 flavonil 1 4 dihydropyridine derivatives YÖKSİS SJR Q1 JCR Q3 OpenAlex 54.8%